vs

Side-by-side financial comparison of U S PHYSICAL THERAPY INC (USPH) and Walker & Dunlop, Inc. (WD). Click either name above to swap in a different company.

Walker & Dunlop, Inc. is the larger business by last-quarter revenue ($340.0M vs $202.7M, roughly 1.7× U S PHYSICAL THERAPY INC). U S PHYSICAL THERAPY INC runs the higher net margin — 2.0% vs -12.9%, a 15.0% gap on every dollar of revenue. On growth, U S PHYSICAL THERAPY INC posted the faster year-over-year revenue change (12.3% vs -0.4%). U S PHYSICAL THERAPY INC produced more free cash flow last quarter ($21.0M vs $-680.1M). Over the past eight quarters, Walker & Dunlop, Inc.'s revenue compounded faster (22.1% CAGR vs 14.1%).

U.S. Physical Therapy Inc. operates hundreds of outpatient physical therapy clinics across the U.S. It offers rehabilitative care for patients recovering from injuries, surgeries, chronic pain and mobility impairments, plus specialized services including sports medicine and pediatric rehabilitation.

Walker & Dunlop, Inc. is one of the largest commercial real estate finance and advisory services firms in the United States and internationally.

USPH vs WD — Head-to-Head

Bigger by revenue
WD
WD
1.7× larger
WD
$340.0M
$202.7M
USPH
Growing faster (revenue YoY)
USPH
USPH
+12.8% gap
USPH
12.3%
-0.4%
WD
Higher net margin
USPH
USPH
15.0% more per $
USPH
2.0%
-12.9%
WD
More free cash flow
USPH
USPH
$701.1M more FCF
USPH
$21.0M
$-680.1M
WD
Faster 2-yr revenue CAGR
WD
WD
Annualised
WD
22.1%
14.1%
USPH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
USPH
USPH
WD
WD
Revenue
$202.7M
$340.0M
Net Profit
$4.2M
$-13.9M
Gross Margin
19.8%
Operating Margin
8.3%
-17.2%
Net Margin
2.0%
-12.9%
Revenue YoY
12.3%
-0.4%
Net Profit YoY
-55.1%
-131.0%
EPS (diluted)
$-0.44
$-0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
USPH
USPH
WD
WD
Q4 25
$202.7M
$340.0M
Q3 25
$197.1M
$337.7M
Q2 25
$197.3M
$319.2M
Q1 25
$183.8M
$237.4M
Q4 24
$180.4M
$341.5M
Q3 24
$168.0M
$292.3M
Q2 24
$167.2M
$270.7M
Q1 24
$155.7M
$228.1M
Net Profit
USPH
USPH
WD
WD
Q4 25
$4.2M
$-13.9M
Q3 25
$13.1M
$33.5M
Q2 25
$12.4M
$34.0M
Q1 25
$9.9M
$2.8M
Q4 24
$9.2M
$44.8M
Q3 24
$6.6M
$28.8M
Q2 24
$7.5M
$22.7M
Q1 24
$8.0M
$11.9M
Gross Margin
USPH
USPH
WD
WD
Q4 25
19.8%
Q3 25
18.7%
Q2 25
21.1%
Q1 25
16.9%
Q4 24
18.0%
Q3 24
17.3%
Q2 24
20.3%
Q1 24
18.2%
Operating Margin
USPH
USPH
WD
WD
Q4 25
8.3%
-17.2%
Q3 25
12.8%
13.6%
Q2 25
12.6%
14.5%
Q1 25
10.7%
2.2%
Q4 24
10.9%
15.3%
Q3 24
7.6%
12.8%
Q2 24
9.3%
10.4%
Q1 24
9.6%
6.0%
Net Margin
USPH
USPH
WD
WD
Q4 25
2.0%
-12.9%
Q3 25
6.7%
9.9%
Q2 25
6.3%
10.6%
Q1 25
5.4%
1.2%
Q4 24
5.1%
13.1%
Q3 24
3.9%
9.9%
Q2 24
4.5%
8.4%
Q1 24
5.2%
5.2%
EPS (diluted)
USPH
USPH
WD
WD
Q4 25
$-0.44
$-0.41
Q3 25
$0.48
$0.98
Q2 25
$0.58
$0.99
Q1 25
$0.80
$0.08
Q4 24
$0.52
$1.32
Q3 24
$0.39
$0.85
Q2 24
$0.47
$0.67
Q1 24
$0.46
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
USPH
USPH
WD
WD
Cash + ST InvestmentsLiquidity on hand
$35.6M
$299.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$476.4M
$1.7B
Total Assets
$1.2B
$5.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
USPH
USPH
WD
WD
Q4 25
$35.6M
$299.3M
Q3 25
$31.1M
$274.8M
Q2 25
$34.1M
$233.7M
Q1 25
$39.2M
$181.0M
Q4 24
$41.4M
$279.3M
Q3 24
$117.0M
$179.8M
Q2 24
$112.9M
$208.1M
Q1 24
$132.3M
$216.5M
Stockholders' Equity
USPH
USPH
WD
WD
Q4 25
$476.4M
$1.7B
Q3 25
$503.6M
$1.8B
Q2 25
$500.8M
$1.8B
Q1 25
$497.3M
$1.7B
Q4 24
$488.9M
$1.7B
Q3 24
$482.8M
$1.7B
Q2 24
$484.6M
$1.7B
Q1 24
$479.8M
$1.7B
Total Assets
USPH
USPH
WD
WD
Q4 25
$1.2B
$5.1B
Q3 25
$1.2B
$5.8B
Q2 25
$1.2B
$4.7B
Q1 25
$1.2B
$4.5B
Q4 24
$1.2B
$4.4B
Q3 24
$1.0B
$4.6B
Q2 24
$1.0B
$4.2B
Q1 24
$1.0B
$3.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
USPH
USPH
WD
WD
Operating Cash FlowLast quarter
$24.9M
$-664.3M
Free Cash FlowOCF − Capex
$21.0M
$-680.1M
FCF MarginFCF / Revenue
10.4%
-200.0%
Capex IntensityCapex / Revenue
1.9%
4.6%
Cash ConversionOCF / Net Profit
6.00×
TTM Free Cash FlowTrailing 4 quarters
$61.0M
$-2.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
USPH
USPH
WD
WD
Q4 25
$24.9M
$-664.3M
Q3 25
$19.9M
$-948.1M
Q2 25
$34.9M
$-238.5M
Q1 25
$-4.7M
$-281.1M
Q4 24
$19.4M
$129.4M
Q3 24
$22.1M
$-202.0M
Q2 24
$29.0M
$-237.8M
Q1 24
$4.4M
$38.4M
Free Cash Flow
USPH
USPH
WD
WD
Q4 25
$21.0M
$-680.1M
Q3 25
$15.6M
$-950.4M
Q2 25
$31.6M
$-241.0M
Q1 25
$-7.3M
$-284.7M
Q4 24
$16.9M
$116.4M
Q3 24
$19.6M
$-204.0M
Q2 24
$26.7M
$-241.7M
Q1 24
$2.6M
$35.2M
FCF Margin
USPH
USPH
WD
WD
Q4 25
10.4%
-200.0%
Q3 25
7.9%
-281.5%
Q2 25
16.0%
-75.5%
Q1 25
-3.9%
-120.0%
Q4 24
9.4%
34.1%
Q3 24
11.7%
-69.8%
Q2 24
15.9%
-89.3%
Q1 24
1.7%
15.4%
Capex Intensity
USPH
USPH
WD
WD
Q4 25
1.9%
4.6%
Q3 25
2.2%
0.7%
Q2 25
1.6%
0.8%
Q1 25
1.4%
1.5%
Q4 24
1.4%
3.8%
Q3 24
1.5%
0.7%
Q2 24
1.4%
1.4%
Q1 24
1.2%
1.4%
Cash Conversion
USPH
USPH
WD
WD
Q4 25
6.00×
Q3 25
1.52×
-28.34×
Q2 25
2.81×
-7.02×
Q1 25
-0.47×
-102.07×
Q4 24
2.10×
2.89×
Q3 24
3.34×
-7.01×
Q2 24
3.86×
-10.49×
Q1 24
0.55×
3.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

USPH
USPH

Net Patient Revenues$169.7M84%
Industrial Injury Prevention Services Revenues$28.9M14%
Management Contract Revenues$2.3M1%

WD
WD

Segment breakdown not available.

Related Comparisons